-
EP1965789
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1965789
| EP1965789 - COMBINATION OF A 5-HT4 AGONIST WITH A CHOLINESTERASE INHIBITOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 04.11.2011 Database last updated on 18.11.2024 | Most recent event Tooltip | 04.11.2011 | Application deemed to be withdrawn | published on 07.12.2011 [2011/49] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [N/P] |
| Former [2008/37] | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | Inventor(s) | 01 /
EARNEST, David, Lewis 6 Forest Dale Drive Morristown, NJ 07960 / US | [2008/37] | Representative(s) | Barbier, Denis Robert Novartis Pharma AG Patent Department 4002 Basel / CH | [N/P] |
| Former [2008/37] | Barbier, Denis Robert Novartis Pharma AG Patent Department 4002 Basel / CH | Application number, filing date | 06841058.8 | 20.12.2006 | [2008/37] | WO2006EP12312 | Priority number, date | GB20050026258 | 22.12.2005 Original published format: GB 0526258 | [2008/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007071394 | Date: | 28.06.2007 | Language: | EN | [2007/26] | Type: | A2 Application without search report | No.: | EP1965789 | Date: | 10.09.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.06.2007 takes the place of the publication of the European patent application. | [2008/37] | Search report(s) | International search report - published on: | EP | 27.03.2008 | Classification | IPC: | A61K31/27, A61K31/4045, A61P1/00 | [2008/37] | CPC: |
A61K31/27 (EP,KR,US);
A61K31/4045 (EP,KR,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/06 (EP);
A61P1/10 (EP);
| C-Set: |
A61K31/27, A61K2300/00 (EP,US);
A61K31/4045, A61K2300/00 (US,EP) | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/37] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | KOMBINATION EINES 5-HT4-AGONISTEN MIT EINEM CHOLINESTERASE-HEMMER | [2008/37] | English: | COMBINATION OF A 5-HT4 AGONIST WITH A CHOLINESTERASE INHIBITOR | [2008/37] | French: | COMBINAISON D'UN AGONISTE DE 5-HT4 ET D'UN INHIBITEUR DE LA CHOLINESTERASE | [2008/37] | Entry into regional phase | 22.07.2008 | National basic fee paid | 29.09.2008 | Designation fee(s) paid | 29.09.2008 | Examination fee paid | Examination procedure | 29.09.2008 | Examination requested [2008/46] | 04.02.2011 | Despatch of a communication from the examining division (Time limit: M04) | 15.06.2011 | Application deemed to be withdrawn, date of legal effect [2011/49] | 19.07.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/49] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.02.2011 | Fees paid | Renewal fee | 15.12.2008 | Renewal fee patent year 03 | 11.12.2009 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.12.2010 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [E]WO2007058805 (EPIX PHARM INC [US], et al) [E] 1,2,4,6-13 * paragraphs [0019] - [0030] - [0066]; example -; claim - *; | [X]JP2005097277 ; | [X] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2005, no. 30, Database accession no. 2005-289277, XP002463038 & JP2005097277 A 20050414 (EISAI CO LTD) [X] 1-3,5,7-11 * abstract * | [X] - MOSER P C ET AL, "SL65.0155, A Novel 5-Hydroxytryptamine4 Receptor Partial Agonist with Potent Cognition-Enhancing Properties", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTIC, US, (2002), vol. 302, no. 2, ISSN 0022-3565, pages 731 - 741, XP007902745 [X] 1,2,4,7-11 * abstract * DOI: http://dx.doi.org/10.1124/jpet.102.034249 | [X] - LAMIRAULT L ET AL, "COMBINED TREATMENT WITH GALANTHAMINIUM BROMIDE, A NEW CHOLINESTERASE INHIBITOR, AND RS 67333, A PARTIAL AGONIST OF 5-HT4 RECEPTORS, ENHANCES PLACE AND OBJECT RECOGNITION IN YOUNG ADULT AND OLD RATS", PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, OXFORD, GB, (200302), vol. 27, no. 1, ISSN 0278-5846, pages 185 - 195, XP008043794 [X] 1,2,4,7-11 * abstract * DOI: http://dx.doi.org/10.1016/S0278-5846(02)00351-2 | [PA] - CAMPBELL-DITTMEYER KRISTEN ET AL, "Study to examine the synergistic effect of a cholinesterase inhibitor and a 5ht(4) agonist on colonic transit", GASTROENTEROLOGY, & DIGESTIVE DISEASE WEEK MEETING/108TH ANNUAL MEETING OF THE AMERICAN-GASTROENTEROLOGICAL-ASSOCIATION; WASHINGTON, DC, USA; MAY 19 24, 2007, (200704), vol. 132, no. 4, Suppl. 2, ISSN 0016-5085, page A686, XP002463037 |